Literature DB >> 16507367

Chemical genetic analysis of the time course of signal transduction by JNK.

Juan-Jose Ventura1, Anette Hübner, Chao Zhang, Richard A Flavell, Kevan M Shokat, Roger J Davis.   

Abstract

Exposure of primary murine embryonic fibroblasts to tumor necrosis factor (TNF) causes biphasic activation of the c-Jun NH(2)-terminal kinase (JNK) signaling pathway. The early phase (30 min) of the response to TNF is a large and transient increase in JNK activity. This response is followed by a second and more sustained phase of JNK activation that lasts many hours. We employed a chemical genetic strategy to dissect the functional consequences of these two phases of JNK activation. We report that both the early and late phases of JNK activation contribute to TNF-induced gene expression. In contrast, the early transient phase of JNK activation (<1 hr) can signal cell survival, while the later and more sustained phase of JNK activation (1-6 hr) can mediate proapoptotic signaling. These data indicate that the time course of JNK signaling can influence the biological response to JNK activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507367     DOI: 10.1016/j.molcel.2006.01.018

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  133 in total

1.  RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the activity of phosphorylated-MKK7.

Authors:  S Takahashi; A Ebihara; H Kajiho; K Kontani; H Nishina; T Katada
Journal:  Cell Death Differ       Date:  2010-11-19       Impact factor: 15.828

2.  Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosis.

Authors:  Max R Banko; Jasmina J Allen; Bethany E Schaffer; Erik W Wilker; Peiling Tsou; Jamie L White; Judit Villén; Beatrice Wang; Sara R Kim; Kei Sakamoto; Steven P Gygi; Lewis C Cantley; Michael B Yaffe; Kevan M Shokat; Anne Brunet
Journal:  Mol Cell       Date:  2011-12-01       Impact factor: 17.970

Review 3.  The UPR and cell fate at a glance.

Authors:  Philip I Merksamer; Feroz R Papa
Journal:  J Cell Sci       Date:  2010-04-01       Impact factor: 5.285

Review 4.  MAPK signaling in inflammation-associated cancer development.

Authors:  Pengyu Huang; Jiahuai Han; Lijian Hui
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

5.  Foxo and Fos regulate the decision between cell death and survival in response to UV irradiation.

Authors:  Xi Luo; Oscar Puig; Joogyung Hyun; Dirk Bohmann; Heinrich Jasper
Journal:  EMBO J       Date:  2006-12-21       Impact factor: 11.598

Review 6.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

7.  Requirements for PKC-augmented JNK activation by MKK4/7.

Authors:  Pablo Lopez-Bergami; Ze'ev Ronai
Journal:  Int J Biochem Cell Biol       Date:  2007-12-03       Impact factor: 5.085

8.  Mitochondrial apoptosis induced by BH3-only molecules in the exclusive presence of endoplasmic reticular Bak.

Authors:  Martina Klee; Kathrin Pallauf; Sonia Alcalá; Aarne Fleischer; Felipe X Pimentel-Muiños
Journal:  EMBO J       Date:  2009-04-02       Impact factor: 11.598

9.  F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 (MKK6).

Authors:  Jia Liu; Liang Han; Bin Li; Jie Yang; Michael S Y Huen; Xin Pan; Sai Wah Tsao; Annie L M Cheung
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

10.  Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells.

Authors:  Shigeo Ohba; Yuichi Hirose; Takeshi Kawase; Hirotoshi Sano
Journal:  J Neurooncol       Date:  2009-06-11       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.